Abstract:As a permanent state of cell cycle arrest, cellular senescence has become an important factor in aging and age-related diseases. As a central regulator of physiology and pathology associated with cellular senescence, the senescence associated secretory phenotype can create an inflammatory and catabolic environment through autocrine and paracrine ways, ultimately affecting tissue microstructure. As an age-related disease, the correlation between intervertebral disc degeneration and cellular senescence has been confirmed by many studies. Various pathological factors in the microenvironment of intervertebral disc degeneration promote senescent cells to produce and accumulate and express excessive senescence associated secretory phenotype. In this case, senescence associated secretory phenotype has received considerable attention as a potential target for delaying or treating disc degeneration. Therefore, we reviewed the latest research progress of senescence associated secretory phenotype, related regulatory mechanisms and intervertebral disc cell senescence treatment strategies. It is expected that further understanding of the underlying mechanism between cellular senescence pathology and intervertebral disc degeneration will help to formulate reasonable senescence regulation strategies, so as to achieve ideal therapeutic effects.The translational potential of this article: Existing treatment strategies often fall short in addressing the challenge of repairing intervertebral disc Intervertebral disc degeneration(IVD) degeneration. The accumulation of senescent cells and the continuous release of senescence-associated secretory phenotype (SASP) perpetually impede disc homeostasis and hinder tissue regeneration. This impairment in repair capability presents a significant obstacle to the practical clinical implementation of strategies for intervertebral disc degeneration. As a result, we present a comprehensive overview of the latest advancements in research, the associated regulatory mechanisms, and strategies for treating SASP in IVD cells. This article aims to investigate effective interventions for delaying the onset and progression of age-related intervertebral disc degeneration. In an era where the aging population is becoming increasingly prominent, this endeavor holds paramount practical and translational significance.

Aging, cell senescence, the pathogenesis and targeted therapies of intervertebral disc degeneration

Cell Senescence: A Nonnegligible Cell State under Survival Stress in Pathology of Intervertebral Disc Degeneration

Regulatory role of hypoxia inducible factor in the biological behavior of nucleus pulposus cells.

Cellular senescence – Molecular mechanisms of intervertebral disc degeneration from an immune perspective

Targeting NP cell senescence in IVDD

The pathogenesis and targeted therapies of intervertebral disc degeneration induced by cartilage endplate inflammation

The Cell Biology of Intervertebral Disc Aging and Degeneration

The cell biology of intervertebral disc aging and degeneration.

Aging and Age Related Stresses: a Senescence Mechanism of Intervertebral Disc Degeneration

Stem Cell Senescence: the Obstacle of the Treatment of Degenerative Disk Disease

Stem Cell Senescence: The Obstacle of the Treatment of Degenerative Disk Disease.

Cell and Molecular Biology of Intervertebral Disc Degeneration: Current Understanding and Implications for Potential Therapeutic Strategies

Mechanisms and therapeutic strategies for senescence-associated secretory phenotype in the intervertebral disc degeneration microenvironment

Intervertebral disc degeneration related molecular biological factors

The role of nerve fibers and their neurotransmitters in regulating intervertebral disc degeneration

Innovative immune mechanisms and antioxidative therapies of intervertebral disc degeneration

Progress in the Study of Molecular Mechanisms of Intervertebral Disc Degeneration

Disc cell senescence in intervertebral disc degeneration: Causes and molecular pathways

[Research progress of cellular senescence and senescent secretary phenotype in intervertebral disc degeneration]

Oxidative Stress and Intervertebral Disc Degeneration: Pathophysiology, Signaling Pathway, and Therapy

Role of Advanced Glycation End Products in Intervertebral Disc Degeneration: Mechanism and Therapeutic Potential